Biofrontera Inc. 10-Q filing
Filed 2026-05-14 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001493152-26-023119
- Form type
- 10-Q
- CIK
- 0001858685
- Primary document
- https://www.sec.gov/Archives/edgar/data/1858685/000149315226023119/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Biofrontera Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $10.1M | - | - |
| Operating Income | $-4.3M | - | - |
| Net Income | $-4.8M | - | - |
| Eps Basic | -0.41 | - | - |
| Eps Diluted | -0.41 | - | - |
| Cash And Equivalents | $6.3M | - | - |
| Total Assets | $24.8M | - | - |
| Total Liabilities | $18.7M | - | - |
| Shareholders Equity | $6.1M | - | - |
| Operating Cash Flow | $-70,000 | - | - |
| Capital Expenditures | $5,000 | - | - |